Athersys
ATHX
#11272
Rank
NZ$1.49 M
Marketcap
NZ$0.02418
Share price
-33.50%
Change (1 day)
-98.89%
Change (1 year)

EPS for Athersys (ATHX)

EPS in 2023 (TTM): NZ-$5.04

According to Athersys's latest financial reports the company's current EPS (TTM) is NZ-$3.64. In 2022 the company made an earnings per share (EPS) of NZ-$11.70 a decrease over its 2021 EPS that were of NZ-$3.73.

EPS history for Athersys from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ-$5.04-56.86%
2022NZ-$11.70213.94%
2021NZ-$3.73395.24%
2020NZ-$0.7544.83%
2019NZ-$0.5261.11%
2018NZ-$0.32-37.93%
2017NZ-$0.5270.59%
2016NZ-$0.30-19.05%
2015NZ-$0.38-25%
2014NZ-$0.50-48.15%
2013NZ-$0.9710.2%
2012NZ-$0.88-18.33%
2011NZ-$1.07-0%
2010NZ-$1.07-25.93%
2009NZ-$1.45-15.62%
2008NZ-$1.72-96.39%
2007NZ-$47.58-61.05%
2006NZ-$122.15
2005N/A

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$11.97-429.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$1.36-137.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$29.05-899.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.41-193.74%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$1.78-148.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.10-322.66%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
NZ$8.40-331.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
NZ-$14.31 293.60%๐Ÿ‡บ๐Ÿ‡ธ USA